Literature DB >> 21674202

Effect of vitamin K on bone mineral density: a meta-analysis of randomized controlled trials.

Yanfu Fang1, Chuanlai Hu, Xingyong Tao, Yuhui Wan, Fangbiao Tao.   

Abstract

A number of randomized controlled trials (RCTs) examining the role of vitamin K on bone mineral density (BMD) have yielded inconsistent results. We performed a meta-analysis of these trials to assess the effect of vitamin K on BMD. We searched MEDLINE, EMBASE and CENTRAL for relevant studies of RCTs examining the role of vitamin K on BMD. Data on participants, interventions, and outcomes were extracted and the quality of all included trials assessed. Primary outcomes for analysis were absolute changes in BMD (mg/cm(2)) at the lumbar spine and femoral neck. Relative changes (percentage change) in BMD at the lumbar spine were also assessed. Vitamin K supplementation was shown to be efficacious in increasing BMD at the lumbar spine but not the femoral neck. The weighted mean difference (WMD) in BMD absolute change was 21.60 mg/cm(2) [95% confidence interval (CI) 3.63, 39.56] at the lumbar spine and 0.25 mg/cm(2) (95% CI -2.64, 3.14) at the femoral neck. The WMD in BMD relative change was 1.27% (95% CI 0.47, 2.06) at the lumbar spine and 0.17 (95% CI -0.21, 0.54) at the femoral neck. Subgroup analysis revealed that ethnic difference, gender, and vitamin K type were associated with variable effects on BMD at the lumbar spine. The modest overall treatment effects for vitamin K on BMD observed in this review may be biased and should be interpreted with caution. Further studies are required to address factors relating to the observed effects of vitamin K on BMD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21674202     DOI: 10.1007/s00774-011-0287-3

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  48 in total

Review 1.  Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials.

Authors:  Sarah Cockayne; Joy Adamson; Susan Lanham-New; Martin J Shearer; Simon Gilbody; David J Torgerson
Journal:  Arch Intern Med       Date:  2006-06-26

2.  Vitamin K2 treatment for postmenopausal osteoporosis in Indonesia.

Authors:  Yuditiya Purwosunu; Ichramsyah A Rachman; Soelarto Reksoprodjo; Akihiko Sekizawa
Journal:  J Obstet Gynaecol Res       Date:  2006-04       Impact factor: 1.730

3.  [Follow-up study of bone mineral density in postmenopausal patients with primary biliary cirrhosis].

Authors:  P L Lakatos; G Firneisz; P Lakatos; C Horváth; F Szalay
Journal:  Orv Hetil       Date:  2001-03-11       Impact factor: 0.540

4.  Differentiation of Caucasians and Chinese at bone mass candidate genes: implication for ethnic difference of bone mass.

Authors:  V Dvornyk; X-H Liu; H Shen; S-F Lei; L-J Zhao; Q-R Huang; Y-J Qin; D-K Jiang; J-R Long; Y-Y Zhang; G Gong; R R Recker; H-W Deng
Journal:  Ann Hum Genet       Date:  2003-05       Impact factor: 1.670

5.  Randomized controlled study on the prevention of osteoporotic fractures (OF study): a phase IV clinical study of 15-mg menatetrenone capsules.

Authors:  Tetsuo Inoue; Toshiharu Fujita; Hideaki Kishimoto; Toshitaka Makino; Tetsuro Nakamura; Toshitaka Nakamura; Tosiya Sato; Kaoru Yamazaki
Journal:  J Bone Miner Metab       Date:  2008-12-12       Impact factor: 2.626

Review 6.  [Drug therapy of secondary osteoporosis: glucocorticoid-induced osteoporosis].

Authors:  Satoshi Soen
Journal:  Nihon Rinsho       Date:  2009-05

7.  Vitamin K intake and hip fractures in women: a prospective study.

Authors:  D Feskanich; P Weber; W C Willett; H Rockett; S L Booth; G A Colditz
Journal:  Am J Clin Nutr       Date:  1999-01       Impact factor: 7.045

8.  Vitamin K2 inhibits osteoclastic bone resorption by inducing osteoclast apoptosis.

Authors:  T Kameda; K Miyazawa; Y Mori; T Yuasa; M Shiokawa; Y Nakamaru; H Mano; Y Hakeda; A Kameda; M Kumegawa
Journal:  Biochem Biophys Res Commun       Date:  1996-03-27       Impact factor: 3.575

9.  Vitamin K dependent in vitro production of prothrombin.

Authors:  J C Swanson; J W Suttie
Journal:  Biochemistry       Date:  1982-11-09       Impact factor: 3.162

10.  Bone recognition mechanism of porcine osteocalcin from crystal structure.

Authors:  Quyen Q Hoang; Frank Sicheri; Andrew J Howard; Daniel S C Yang
Journal:  Nature       Date:  2003-10-30       Impact factor: 49.962

View more
  26 in total

1.  Comparison of concurrent treatment with vitamin K2 and risedronate compared with treatment with risedronate alone in patients with osteoporosis: Japanese Osteoporosis Intervention Trial-03.

Authors:  Shiro Tanaka; Teruhiko Miyazaki; Yukari Uemura; Nobuaki Miyakawa; Itsuo Gorai; Toshitaka Nakamura; Masao Fukunaga; Yasuo Ohashi; Hiroaki Ohta; Satoshi Mori; Hiroshi Hagino; Takayuki Hosoi; Toshitsugu Sugimoto; Eiji Itoi; Hajime Orimo; Masataka Shiraki
Journal:  J Bone Miner Metab       Date:  2016-08-02       Impact factor: 2.626

2.  Vitamin K supplementation for the primary prevention of osteoporotic fractures: is it cost-effective and is future research warranted?

Authors:  O Gajic-Veljanoski; A M Bayoumi; G Tomlinson; K Khan; A M Cheung
Journal:  Osteoporos Int       Date:  2012-03-08       Impact factor: 4.507

3.  Serum level of under-carboxylated osteocalcin and bone mineral density in early menopausal Norwegian women.

Authors:  Nina Emaus; Nguyen D Nguyen; Bjørg Almaas; Gro K Berntsen; Jacqueline R Center; Monika Christensen; Clara G Gjesdal; Anne S Grimsgaard; Tuan V Nguyen; Laila Salomonsen; John A Eisman; Vinjar M Fønnebø
Journal:  Eur J Nutr       Date:  2011-11-30       Impact factor: 5.614

4.  Design of a randomized clinical trial of concurrent treatment with vitamin K2 and risedronate compared to risedronate alone in osteoporotic patients: Japanese Osteoporosis Intervention Trial-03 (JOINT-03).

Authors:  Shiro Tanaka; Teruhiko Miyazaki; Yukari Uemura; Tatsuhiko Kuroda; Nobuaki Miyakawa; Toshitaka Nakamura; Masao Fukunaga; Yasuo Ohashi; Hiroaki Ohta; Satoshi Mori; Hiroshi Hagino; Takayuki Hosoi; Toshitsugu Sugimoto; Eiji Itoi; Hajime Orimo; Masataka Shiraki
Journal:  J Bone Miner Metab       Date:  2013-07-05       Impact factor: 2.626

Review 5.  Menaquinones, bacteria, and the food supply: the relevance of dairy and fermented food products to vitamin K requirements.

Authors:  Barbara Walther; J Philip Karl; Sarah L Booth; Patrick Boyaval
Journal:  Adv Nutr       Date:  2013-07-01       Impact factor: 8.701

Review 6.  Vitamin K-dependent carboxylation of osteocalcin: friend or foe?

Authors:  Caren M Gundberg; Jane B Lian; Sarah L Booth
Journal:  Adv Nutr       Date:  2012-03-01       Impact factor: 8.701

7.  Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials.

Authors:  Z-B Huang; S-L Wan; Y-J Lu; L Ning; C Liu; S-W Fan
Journal:  Osteoporos Int       Date:  2014-12-17       Impact factor: 4.507

8.  Effect of 1-year dietary supplementation with vitaminized olive oil on markers of bone turnover and oxidative stress in healthy post-menopausal women.

Authors:  Laura Mazzanti; Maurizio Battino; Laura Nanetti; Francesca Raffaelli; Alessandro Alidori; Giulia Sforza; Flavia Carle; Veronica Quagliarini; Nelvio Cester; Arianna Vignini
Journal:  Endocrine       Date:  2015-01-20       Impact factor: 3.633

9.  Low-dose vitamin K2 (MK-4) supplementation for 12 months improves bone metabolism and prevents forearm bone loss in postmenopausal Japanese women.

Authors:  Noriko Koitaya; Mariko Sekiguchi; Yuko Tousen; Yoriko Nishide; Akemi Morita; Jun Yamauchi; Yuko Gando; Motohiko Miyachi; Mami Aoki; Miho Komatsu; Fumiko Watanabe; Koji Morishita; Yoshiko Ishimi
Journal:  J Bone Miner Metab       Date:  2013-05-24       Impact factor: 2.626

Review 10.  Effects of bioactive lipids and lipoproteins on bone.

Authors:  Yin Tintut; Linda L Demer
Journal:  Trends Endocrinol Metab       Date:  2013-10-30       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.